Skip to main content
. 2023 Sep 12;6:0211. doi: 10.34133/research.0211

Fig. 2.

Fig. 2.

(A) Schematic illustration of size-transformable supramolecular nanoprodrug (PDNP)-mediated cancer chemo-immunotherapy. (B) pH-triggered sequential conversion of particle size over time. (C) Representative immunofluorescence staining of excised tumor tissues after PDNP treatment for penetration studies. Reproduced with permission from [67]. Copyright 2022 Wiley-VCH GmbH.